{"id":339478,"date":"2025-08-19T18:16:30","date_gmt":"2025-08-19T18:16:30","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-gilead-sciences\/"},"modified":"2025-08-19T18:16:30","modified_gmt":"2025-08-19T18:16:30","slug":"how-to-buy-gilead-sciences","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334054,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-339478","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Gilead Sciences, Inc. (GILD) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Gilead Sciences, Inc. (GILD) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, \u0111\u00e1nh gi\u00e1 r\u1ee7i ro v\u00e0 h\u01b0\u1edbng d\u1eabn mua t\u1eebng b\u01b0\u1edbc cho n\u0103m 2025.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, \u0111\u00e1nh gi\u00e1 r\u1ee7i ro v\u00e0 h\u01b0\u1edbng d\u1eabn mua t\u1eebng b\u01b0\u1edbc cho n\u0103m 2025."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o m\u1ed9t t\u1eadp \u0111o\u00e0n d\u01b0\u1ee3c ph\u1ea9m \u0111ang c\u00e1ch m\u1ea1ng h\u00f3a \u0111i\u1ec1u tr\u1ecb HIV? Gilead Sciences (GILD) k\u1ebft h\u1ee3p \u0111\u1ed5i m\u1edbi y h\u1ecdc v\u1edbi s\u1ef1 \u1ed5n \u0111\u1ecbnh t\u00e0i ch\u00ednh\u2014ho\u00e0n h\u1ea3o cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi. V\u1edbi c\u00e1c li\u1ec7u ph\u00e1p \u0111\u1ed9t ph\u00e1 nh\u01b0 Biktarvy v\u00e0 thu\u1ed1c ph\u00f2ng ng\u1eeba HIV \u0111\u1ea7u ti\u00ean tr\u00ean th\u1ebf gi\u1edbi d\u00f9ng hai l\u1ea7n m\u1ed7i n\u0103m, c\u00f4ng ty n\u00e0y \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi tr\u00ean to\u00e0n c\u1ea7u. Ch\u00fang ta s\u1ebd kh\u00e1m ph\u00e1 m\u1ecdi th\u1ee9: hi\u1ec7u su\u1ea5t c\u1ed5 phi\u1ebfu hi\u1ec7n t\u1ea1i, chi\u1ebfn l\u01b0\u1ee3c v\u00e0o l\u1ec7nh th\u00f4ng minh, v\u00e0 l\u00fd do t\u1ea1i sao n\u0103m 2025 mang l\u1ea1i c\u01a1 h\u1ed9i \u0111\u1ed9c \u0111\u00e1o.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o m\u1ed9t t\u1eadp \u0111o\u00e0n d\u01b0\u1ee3c ph\u1ea9m \u0111ang c\u00e1ch m\u1ea1ng h\u00f3a \u0111i\u1ec1u tr\u1ecb HIV? Gilead Sciences (GILD) k\u1ebft h\u1ee3p \u0111\u1ed5i m\u1edbi y h\u1ecdc v\u1edbi s\u1ef1 \u1ed5n \u0111\u1ecbnh t\u00e0i ch\u00ednh\u2014ho\u00e0n h\u1ea3o cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi. V\u1edbi c\u00e1c li\u1ec7u ph\u00e1p \u0111\u1ed9t ph\u00e1 nh\u01b0 Biktarvy v\u00e0 thu\u1ed1c ph\u00f2ng ng\u1eeba HIV \u0111\u1ea7u ti\u00ean tr\u00ean th\u1ebf gi\u1edbi d\u00f9ng hai l\u1ea7n m\u1ed7i n\u0103m, c\u00f4ng ty n\u00e0y \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi tr\u00ean to\u00e0n c\u1ea7u. Ch\u00fang ta s\u1ebd kh\u00e1m ph\u00e1 m\u1ecdi th\u1ee9: hi\u1ec7u su\u1ea5t c\u1ed5 phi\u1ebfu hi\u1ec7n t\u1ea1i, chi\u1ebfn l\u01b0\u1ee3c v\u00e0o l\u1ec7nh th\u00f4ng minh, v\u00e0 l\u00fd do t\u1ea1i sao n\u0103m 2025 mang l\u1ea1i c\u01a1 h\u1ed9i \u0111\u1ed9c \u0111\u00e1o."},"body_html":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Gilead Sciences: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 19 th\u00e1ng 8 n\u0103m 2025, Gilead Sciences, Inc. (GILD) giao d\u1ecbch \u1edf m\u1ee9c <strong>118,85 USD<\/strong> tr\u00ean NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>5 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng\u2014\u0111\u00f3 l\u00e0 khi Gilead c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3. Theo l\u1ecbch s\u1eed, c\u00e1c b\u00e1o c\u00e1o n\u00e0y t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3 trong v\u00e0i gi\u1edd.<\/p> <h3>C\u00e1ch B\u00e1o C\u00e1o L\u1ee3i Nhu\u1eadn \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu GILD<\/h3> <table> <thead> <tr><th>Ng\u00e0y<\/th><th>S\u1ef1 ki\u1ec7n<\/th><th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th><th>Thay \u0110\u1ed5i Sau Tin<\/th><\/tr> <\/thead> <tbody> <tr><td>7 th\u00e1ng 8, 2025<\/td><td>L\u1ee3i nhu\u1eadn qu\u00fd 2<\/td><td>116,20 USD<\/td><td><strong>+2,36%<\/strong> (ngo\u00e0i gi\u1edd giao d\u1ecbch)<\/td><\/tr> <tr><td>8 th\u00e1ng 5, 2025<\/td><td>L\u1ee3i nhu\u1eadn qu\u00fd 1<\/td><td>112,50 USD<\/td><td><strong>+3,1%<\/strong> (ng\u00e0y h\u00f4m sau)<\/td><\/tr> <tr><td>6 th\u00e1ng 2, 2025<\/td><td>K\u1ebft qu\u1ea3 h\u00e0ng n\u0103m<\/td><td>108,75 USD<\/td><td><strong>+4,8%<\/strong> (v\u01b0\u1ee3t d\u1ef1 b\u00e1o)<\/td><\/tr> <tr><td>7 th\u00e1ng 11, 2024<\/td><td>Ra m\u1eaft s\u1ea3n ph\u1ea9m<\/td><td>104,30 USD<\/td><td><strong>+2,9%<\/strong> (3 ng\u00e0y)<\/td><\/tr> <tr><td>8 th\u00e1ng 8, 2024<\/td><td>L\u1ee3i nhu\u1eadn qu\u00fd 2<\/td><td>102,10 USD<\/td><td><strong>-1,2%<\/strong> (kh\u00f4ng \u0111\u1ea1t m\u1ee5c ti\u00eau)<\/td><\/tr> <tr><td>9 th\u00e1ng 5, 2024<\/td><td>Ph\u00ea duy\u1ec7t FDA<\/td><td>98,40 USD<\/td><td><strong>+5,3%<\/strong> (h\u00e0o h\u1ee9ng nh\u00e0 \u0111\u1ea7u t\u01b0)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Nh\u1eadn \u0111\u1ecbnh xu h\u01b0\u1edbng<\/strong>: C\u00e1c b\u1ea5t ng\u1edd t\u00edch c\u1ef1c v\u1ec1 l\u1ee3i nhu\u1eadn th\u01b0\u1eddng \u0111\u1ea9y gi\u00e1 t\u0103ng ngay l\u1eadp t\u1ee9c, trong khi c\u00e1c k\u1ebft qu\u1ea3 kh\u00f4ng \u0111\u1ea1t g\u00e2y gi\u1ea3m ng\u1eafn h\u1ea1n\u2014nh\u01b0ng GILD th\u01b0\u1eddng h\u1ed3i ph\u1ee5c nhanh nh\u1edd v\u1ecb th\u1ebf m\u1ea1nh trong l\u0129nh v\u1ef1c HIV.<\/p>  [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 2 - Th\u00e1ng 8 n\u0103m 2025)<\/h2> <p>C\u1ed5 phi\u1ebfu Gilead \u0111\u00e3 th\u1ec3 hi\u1ec7n m\u1ee9c <strong>t\u0103ng tr\u01b0\u1edfng 28,2%<\/strong> \u1ea5n t\u01b0\u1ee3ng trong giai \u0111o\u1ea1n n\u00e0y, v\u01b0\u1ee3t xa m\u1ee9c t\u0103ng 3,7% c\u1ee7a ng\u00e0nh:<\/p> <ul> <li><strong>Th\u00e1ng 2<\/strong>: 92,60 USD (h\u1ee3p nh\u1ea5t sau k\u1ef3 ngh\u1ec9 l\u1ec5)<\/li> <li><strong>Th\u00e1ng 4<\/strong>: 105,80 USD (l\u1ee3i nhu\u1eadn qu\u00fd 1 v\u01b0\u1ee3t k\u1ef3 v\u1ecdng)<\/li> <li><strong>Th\u00e1ng 6<\/strong>: 112,40 USD (h\u00e0o h\u1ee9ng ph\u00ea duy\u1ec7t FDA cho li\u1ec7u ph\u00e1p m\u1edbi)<\/li> <li><strong>Th\u00e1ng 8<\/strong>: 118,85 USD (k\u1ebft qu\u1ea3 qu\u00fd 2 v\u01b0\u1ee3t d\u1ef1 b\u00e1o)<\/li> <\/ul> <p><strong>T\u1ea1i sao gi\u00e1 ti\u1ebfp t\u1ee5c t\u0103ng?<\/strong><\/p> <ul> <li>Doanh s\u1ed1 thu\u1ed1c HIV t\u0103ng 7% so v\u1edbi c\u00f9ng k\u1ef3 n\u0103m tr\u01b0\u1edbc, \u0111\u1ea1t 5,1 t\u1ef7 USD<\/li> <li>Biktarvy duy tr\u00ec 49% th\u1ecb ph\u1ea7n M\u1ef9 v\u1edbi t\u0103ng tr\u01b0\u1edfng doanh s\u1ed1 9%<\/li> <li>FDA ph\u00ea duy\u1ec7t Yeztugo\u2014thu\u1ed1c ph\u00f2ng ng\u1eeba HIV hai l\u1ea7n m\u1ed7i n\u0103m mang t\u00ednh c\u00e1ch m\u1ea1ng<\/li> <li>C\u00f4ng ty n\u00e2ng d\u1ef1 b\u00e1o c\u1ea3 n\u0103m nh\u1edd hi\u1ec7u su\u1ea5t m\u1ea1nh m\u1ebd<\/li> <\/ul>  <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 125-135 USD (doanh s\u1ed1 m\u00f9a l\u1ec5 m\u1ea1nh + ch\u1ea5t x\u00fac t\u00e1c trong pipeline) \u2192 <strong>MUA<\/strong><br\/> <strong>2026<\/strong>: 140-150 USD (ra m\u1eaft lenacapavir PrEP + m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng)<br\/> <strong>2028<\/strong>: 160-180 USD (tr\u01b0\u1edfng th\u00e0nh danh m\u1ee5c ung th\u01b0 + t\u0103ng tr\u01b0\u1edfng qu\u1ed1c t\u1ebf)<br\/> <strong>2030<\/strong>: Tr\u00ean 200 USD (nhu c\u1ea7u d\u00e2n s\u1ed1 gi\u00e0 + \u0111\u1ed5i m\u1edbi \u0111\u1ed9t ph\u00e1)<\/p> <p><strong>K\u1ebft lu\u1eadn<\/strong>: R\u1ea5t t\u1ed1t cho <strong>gi\u1eef d\u00e0i h\u1ea1n<\/strong>. Nh\u00e0 giao d\u1ecbch ng\u1eafn h\u1ea1n n\u00ean ch\u00fa \u00fd c\u01a1 h\u1ed9i sau b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn.<\/p>  <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i ro c\u1ea7n c\u00e2n nh\u1eafc<\/h3> <ul> <li><strong>FDA t\u1ea1m d\u1eebng th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong> v\u1edbi thu\u1ed1c HIV GS-1720 v\u00e0 GS-4182\u2014d\u1ef1 ki\u1ebfn tr\u00ec ho\u00e3n 12-18 th\u00e1ng<\/li> <li><strong>B\u1ea5t \u0111\u1ecbnh quy \u0111\u1ecbnh<\/strong> quanh nhi\u1ec1u ch\u01b0\u01a1ng tr\u00ecnh trong pipeline<\/li> <li><strong>Ki\u1ec3m tra ph\u00e1p l\u00fd<\/strong> bao g\u1ed3m \u0111i\u1ec1u tra SEC v\u00e0 c\u00e1c v\u1ee5 ki\u1ec7n t\u1eadp th\u1ec3<\/li> <li><strong>Doanh s\u1ed1 li\u1ec7u ph\u00e1p t\u1ebf b\u00e0o gi\u1ea3m<\/strong> 7% do \u00e1p l\u1ef1c c\u1ea1nh tranh<\/li> <li><strong>R\u1ee7i ro t\u1ef7 gi\u00e1<\/strong> v\u1edbi doanh thu qu\u1ed1c t\u1ebf \u0111\u00e1ng k\u1ec3<\/li> <\/ul> <h3>T\u00edn hi\u1ec7u t\u00edch c\u1ef1c cho n\u0103m 2025<\/h3> <ul> <li><strong>Ph\u00ea duy\u1ec7t Yeztugo<\/strong> - thu\u1ed1c ph\u00f2ng ng\u1eeba HIV hai l\u1ea7n m\u1ed7i n\u0103m \u0111\u1ea7u ti\u00ean tr\u00ean th\u1ebf gi\u1edbi, t\u1ea1o doanh thu 107 tri\u1ec7u USD qu\u00fd \u0111\u1ea7u ti\u00ean<\/li> <li><strong>Th\u1ed1ng tr\u1ecb Biktarvy<\/strong> - t\u0103ng tr\u01b0\u1edfng doanh s\u1ed1 9% l\u00ean 3,5 t\u1ef7 USD v\u1edbi 49% th\u1ecb ph\u1ea7n<\/li> <li><strong>T\u00e0i ch\u00ednh m\u1ea1nh<\/strong> - t\u0103ng tr\u01b0\u1edfng l\u1ee3i nhu\u1eadn r\u00f2ng 21%, n\u00e2ng d\u1ef1 b\u00e1o l\u00ean 28,3-28,7 t\u1ef7 USD<\/li> <li><strong>Ch\u01b0\u01a1ng tr\u00ecnh mua l\u1ea1i c\u1ed5 phi\u1ebfu 6 t\u1ef7 USD<\/strong> th\u1ec3 hi\u1ec7n s\u1ef1 t\u1ef1 tin c\u1ee7a ban l\u00e3nh \u0111\u1ea1o<\/li> <li><strong>\u0110\u1ed5i m\u1edbi trong pipeline<\/strong> - lenacapavir cho hi\u1ec7u qu\u1ea3 100% trong th\u1eed nghi\u1ec7m<\/li> <\/ul>  <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong> - S\u1eed d\u1ee5ng ph\u01b0\u01a1ng ph\u00e1p trung b\u00ecnh gi\u00e1 theo \u0111\u00f4 la v\u1edbi \u0111\u1ea7u t\u01b0 \u0111\u1ecbnh k\u1ef3 thay v\u00ec c\u1ed1 g\u1eafng b\u1eaft th\u1eddi \u0111i\u1ec3m th\u1ecb tr\u01b0\u1eddng<\/li> <li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o l\u1ee3i nhu\u1eadn<\/strong> - Theo d\u00f5i GILD quanh ng\u00e0y 5 th\u00e1ng 11 \u0111\u1ec3 t\u00ecm \u0111i\u1ec3m v\u00e0o ti\u1ec1m n\u0103ng<\/li> <li><strong>\u0110a d\u1ea1ng h\u00f3a kh\u00f4n ngoan<\/strong> - Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 10-15% danh m\u1ee5c v\u00e0o c\u1ed5 phi\u1ebfu d\u01b0\u1ee3c ph\u1ea9m<\/li> <li><strong>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc<\/strong>: \"Giao d\u1ecbch GILD gi\u1ed1ng nh\u01b0 u\u1ed1ng thu\u1ed1c HIV c\u1ee7a h\u1ecd\u2014ki\u00ean \u0111\u1ecbnh h\u01a1n l\u00e0 b\u1eaft \u0111\u00fang th\u1eddi \u0111i\u1ec3m. B\u1ecf li\u1ec1u (ho\u1eb7c b\u1ecf nh\u1ecbp gi\u1ea3m gi\u00e1), b\u1ea1n s\u1ebd h\u1ed1i ti\u1ebfc sau!\"<\/li> <\/ol>  <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Gilead Sciences, Inc. (GILD) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0111\u1ed9ng<\/th><th>T\u1ea1i sao quan tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng \u0111\u1ea7u t\u01b0<\/td><td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng cung c\u1ea5p c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n t\u1ea5t n\u1ea1p ti\u1ec1n t\u00e0i kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n d\u1ec5 qu\u1ea3n l\u00fd\u2014ngay c\u1ea3 50 USD c\u0169ng \u0111\u1ee7 cho \u0111\u1ea7u t\u01b0 c\u1ed5 phi\u1ebfu l\u1ebb<\/td><\/tr> <tr><td>3<\/td><td>T\u00ecm m\u00e3 \"GILD\"<\/td><td>D\u00f9ng \u0111\u00fang k\u00fd hi\u1ec7u, kh\u00f4ng ch\u1ec9 t\u00ecm \"Gilead Sciences\"<\/td><\/tr> <tr><td>4<\/td><td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td><td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o; tr\u00e1nh l\u1ec7nh th\u1ecb tr\u01b0\u1eddng khi bi\u1ebfn \u0111\u1ed9ng<\/td><\/tr> <tr><td>5<\/td><td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td><td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng\u2014nh\u1eafm d\u01b0\u1edbi 0,5% chi ph\u00ed giao d\u1ecbch<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 T\u1ea1i sao Pocket Option ph\u00f9 h\u1ee3p v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi<\/h2> <p>Pocket Option c\u00e1ch m\u1ea1ng h\u00f3a vi\u1ec7c ti\u1ebfp c\u1eadn c\u1ed5 phi\u1ebfu cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong>\u2014ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c kh\u00f4ng r\u1ee7i ro<\/li> <li><strong>Quy tr\u00ecnh KYC 1 ph\u00fat<\/strong>\u2014t\u1ea3i l\u00ean b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n n\u00e0o v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch ngay<\/li> <li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong>\u2014ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed, th\u1ebb ng\u00e2n h\u00e0ng v\u00e0 c\u00e1c l\u1ef1a ch\u1ecdn \u0111\u1ecba ph\u01b0\u01a1ng<\/li> <li><strong>C\u1ed5 phi\u1ebfu l\u1ebb c\u00f3 s\u1eb5n<\/strong>\u2014mua ph\u1ea7n nh\u1ecf c\u1ee7a GILD ngay c\u1ea3 v\u1edbi v\u1ed1n nh\u1ecf<\/li> <\/ul>  <h2>\ud83c\udf0d Gilead Sciences n\u0103m 2025: Nh\u00e0 L\u00e3nh \u0110\u1ea1o \u0110\u1ed5i M\u1edbi Y T\u1ebf<\/h2> <p>Gilead Sciences th\u1ed1ng tr\u1ecb th\u1ecb tr\u01b0\u1eddng \u0111i\u1ec1u tr\u1ecb HIV v\u1edbi g\u1ea7n 50% th\u1ecb ph\u1ea7n M\u1ef9 cho Biktarvy. Ngo\u00e0i thu\u1ed1c kh\u00e1ng virus, c\u00f4ng ty d\u1eabn \u0111\u1ea7u nghi\u00ean c\u1ee9u ung th\u01b0 v\u00e0 \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh vi\u00eam. <strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025<\/strong>: Ph\u00ea duy\u1ec7t Yeztugo c\u1ee7a Gilead t\u1ea1o ra l\u1ef1a ch\u1ecdn ph\u00f2ng ng\u1eeba HIV \u0111\u1ea7u ti\u00ean ch\u1ec9 c\u1ea7n hai li\u1ec1u m\u1ed7i n\u0103m\u2014thay \u0111\u1ed5i cu\u1ed9c s\u1ed1ng h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi tr\u00ean to\u00e0n c\u1ea7u!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Gilead Sciences: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 19 th\u00e1ng 8 n\u0103m 2025, Gilead Sciences, Inc. (GILD) giao d\u1ecbch \u1edf m\u1ee9c <strong>118,85 USD<\/strong> tr\u00ean NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>5 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng\u2014\u0111\u00f3 l\u00e0 khi Gilead c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3. Theo l\u1ecbch s\u1eed, c\u00e1c b\u00e1o c\u00e1o n\u00e0y t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3 trong v\u00e0i gi\u1edd.<\/p>\n<h3>C\u00e1ch B\u00e1o C\u00e1o L\u1ee3i Nhu\u1eadn \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu GILD<\/h3>\n<table>\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 ki\u1ec7n<\/th>\n<th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th>\n<th>Thay \u0110\u1ed5i Sau Tin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>7 th\u00e1ng 8, 2025<\/td>\n<td>L\u1ee3i nhu\u1eadn qu\u00fd 2<\/td>\n<td>116,20 USD<\/td>\n<td><strong>+2,36%<\/strong> (ngo\u00e0i gi\u1edd giao d\u1ecbch)<\/td>\n<\/tr>\n<tr>\n<td>8 th\u00e1ng 5, 2025<\/td>\n<td>L\u1ee3i nhu\u1eadn qu\u00fd 1<\/td>\n<td>112,50 USD<\/td>\n<td><strong>+3,1%<\/strong> (ng\u00e0y h\u00f4m sau)<\/td>\n<\/tr>\n<tr>\n<td>6 th\u00e1ng 2, 2025<\/td>\n<td>K\u1ebft qu\u1ea3 h\u00e0ng n\u0103m<\/td>\n<td>108,75 USD<\/td>\n<td><strong>+4,8%<\/strong> (v\u01b0\u1ee3t d\u1ef1 b\u00e1o)<\/td>\n<\/tr>\n<tr>\n<td>7 th\u00e1ng 11, 2024<\/td>\n<td>Ra m\u1eaft s\u1ea3n ph\u1ea9m<\/td>\n<td>104,30 USD<\/td>\n<td><strong>+2,9%<\/strong> (3 ng\u00e0y)<\/td>\n<\/tr>\n<tr>\n<td>8 th\u00e1ng 8, 2024<\/td>\n<td>L\u1ee3i nhu\u1eadn qu\u00fd 2<\/td>\n<td>102,10 USD<\/td>\n<td><strong>-1,2%<\/strong> (kh\u00f4ng \u0111\u1ea1t m\u1ee5c ti\u00eau)<\/td>\n<\/tr>\n<tr>\n<td>9 th\u00e1ng 5, 2024<\/td>\n<td>Ph\u00ea duy\u1ec7t FDA<\/td>\n<td>98,40 USD<\/td>\n<td><strong>+5,3%<\/strong> (h\u00e0o h\u1ee9ng nh\u00e0 \u0111\u1ea7u t\u01b0)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Nh\u1eadn \u0111\u1ecbnh xu h\u01b0\u1edbng<\/strong>: C\u00e1c b\u1ea5t ng\u1edd t\u00edch c\u1ef1c v\u1ec1 l\u1ee3i nhu\u1eadn th\u01b0\u1eddng \u0111\u1ea9y gi\u00e1 t\u0103ng ngay l\u1eadp t\u1ee9c, trong khi c\u00e1c k\u1ebft qu\u1ea3 kh\u00f4ng \u0111\u1ea1t g\u00e2y gi\u1ea3m ng\u1eafn h\u1ea1n\u2014nh\u01b0ng GILD th\u01b0\u1eddng h\u1ed3i ph\u1ee5c nhanh nh\u1edd v\u1ecb th\u1ebf m\u1ea1nh trong l\u0129nh v\u1ef1c HIV.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 2 &#8211; Th\u00e1ng 8 n\u0103m 2025)<\/h2>\n<p>C\u1ed5 phi\u1ebfu Gilead \u0111\u00e3 th\u1ec3 hi\u1ec7n m\u1ee9c <strong>t\u0103ng tr\u01b0\u1edfng 28,2%<\/strong> \u1ea5n t\u01b0\u1ee3ng trong giai \u0111o\u1ea1n n\u00e0y, v\u01b0\u1ee3t xa m\u1ee9c t\u0103ng 3,7% c\u1ee7a ng\u00e0nh:<\/p>\n<ul>\n<li><strong>Th\u00e1ng 2<\/strong>: 92,60 USD (h\u1ee3p nh\u1ea5t sau k\u1ef3 ngh\u1ec9 l\u1ec5)<\/li>\n<li><strong>Th\u00e1ng 4<\/strong>: 105,80 USD (l\u1ee3i nhu\u1eadn qu\u00fd 1 v\u01b0\u1ee3t k\u1ef3 v\u1ecdng)<\/li>\n<li><strong>Th\u00e1ng 6<\/strong>: 112,40 USD (h\u00e0o h\u1ee9ng ph\u00ea duy\u1ec7t FDA cho li\u1ec7u ph\u00e1p m\u1edbi)<\/li>\n<li><strong>Th\u00e1ng 8<\/strong>: 118,85 USD (k\u1ebft qu\u1ea3 qu\u00fd 2 v\u01b0\u1ee3t d\u1ef1 b\u00e1o)<\/li>\n<\/ul>\n<p><strong>T\u1ea1i sao gi\u00e1 ti\u1ebfp t\u1ee5c t\u0103ng?<\/strong><\/p>\n<ul>\n<li>Doanh s\u1ed1 thu\u1ed1c HIV t\u0103ng 7% so v\u1edbi c\u00f9ng k\u1ef3 n\u0103m tr\u01b0\u1edbc, \u0111\u1ea1t 5,1 t\u1ef7 USD<\/li>\n<li>Biktarvy duy tr\u00ec 49% th\u1ecb ph\u1ea7n M\u1ef9 v\u1edbi t\u0103ng tr\u01b0\u1edfng doanh s\u1ed1 9%<\/li>\n<li>FDA ph\u00ea duy\u1ec7t Yeztugo\u2014thu\u1ed1c ph\u00f2ng ng\u1eeba HIV hai l\u1ea7n m\u1ed7i n\u0103m mang t\u00ednh c\u00e1ch m\u1ea1ng<\/li>\n<li>C\u00f4ng ty n\u00e2ng d\u1ef1 b\u00e1o c\u1ea3 n\u0103m nh\u1edd hi\u1ec7u su\u1ea5t m\u1ea1nh m\u1ebd<\/li>\n<\/ul>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 125-135 USD (doanh s\u1ed1 m\u00f9a l\u1ec5 m\u1ea1nh + ch\u1ea5t x\u00fac t\u00e1c trong pipeline) \u2192 <strong>MUA<\/strong><br \/> <strong>2026<\/strong>: 140-150 USD (ra m\u1eaft lenacapavir PrEP + m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng)<br \/> <strong>2028<\/strong>: 160-180 USD (tr\u01b0\u1edfng th\u00e0nh danh m\u1ee5c ung th\u01b0 + t\u0103ng tr\u01b0\u1edfng qu\u1ed1c t\u1ebf)<br \/> <strong>2030<\/strong>: Tr\u00ean 200 USD (nhu c\u1ea7u d\u00e2n s\u1ed1 gi\u00e0 + \u0111\u1ed5i m\u1edbi \u0111\u1ed9t ph\u00e1)<\/p>\n<p><strong>K\u1ebft lu\u1eadn<\/strong>: R\u1ea5t t\u1ed1t cho <strong>gi\u1eef d\u00e0i h\u1ea1n<\/strong>. Nh\u00e0 giao d\u1ecbch ng\u1eafn h\u1ea1n n\u00ean ch\u00fa \u00fd c\u01a1 h\u1ed9i sau b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i ro c\u1ea7n c\u00e2n nh\u1eafc<\/h3>\n<ul>\n<li><strong>FDA t\u1ea1m d\u1eebng th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong> v\u1edbi thu\u1ed1c HIV GS-1720 v\u00e0 GS-4182\u2014d\u1ef1 ki\u1ebfn tr\u00ec ho\u00e3n 12-18 th\u00e1ng<\/li>\n<li><strong>B\u1ea5t \u0111\u1ecbnh quy \u0111\u1ecbnh<\/strong> quanh nhi\u1ec1u ch\u01b0\u01a1ng tr\u00ecnh trong pipeline<\/li>\n<li><strong>Ki\u1ec3m tra ph\u00e1p l\u00fd<\/strong> bao g\u1ed3m \u0111i\u1ec1u tra SEC v\u00e0 c\u00e1c v\u1ee5 ki\u1ec7n t\u1eadp th\u1ec3<\/li>\n<li><strong>Doanh s\u1ed1 li\u1ec7u ph\u00e1p t\u1ebf b\u00e0o gi\u1ea3m<\/strong> 7% do \u00e1p l\u1ef1c c\u1ea1nh tranh<\/li>\n<li><strong>R\u1ee7i ro t\u1ef7 gi\u00e1<\/strong> v\u1edbi doanh thu qu\u1ed1c t\u1ebf \u0111\u00e1ng k\u1ec3<\/li>\n<\/ul>\n<h3>T\u00edn hi\u1ec7u t\u00edch c\u1ef1c cho n\u0103m 2025<\/h3>\n<ul>\n<li><strong>Ph\u00ea duy\u1ec7t Yeztugo<\/strong> &#8211; thu\u1ed1c ph\u00f2ng ng\u1eeba HIV hai l\u1ea7n m\u1ed7i n\u0103m \u0111\u1ea7u ti\u00ean tr\u00ean th\u1ebf gi\u1edbi, t\u1ea1o doanh thu 107 tri\u1ec7u USD qu\u00fd \u0111\u1ea7u ti\u00ean<\/li>\n<li><strong>Th\u1ed1ng tr\u1ecb Biktarvy<\/strong> &#8211; t\u0103ng tr\u01b0\u1edfng doanh s\u1ed1 9% l\u00ean 3,5 t\u1ef7 USD v\u1edbi 49% th\u1ecb ph\u1ea7n<\/li>\n<li><strong>T\u00e0i ch\u00ednh m\u1ea1nh<\/strong> &#8211; t\u0103ng tr\u01b0\u1edfng l\u1ee3i nhu\u1eadn r\u00f2ng 21%, n\u00e2ng d\u1ef1 b\u00e1o l\u00ean 28,3-28,7 t\u1ef7 USD<\/li>\n<li><strong>Ch\u01b0\u01a1ng tr\u00ecnh mua l\u1ea1i c\u1ed5 phi\u1ebfu 6 t\u1ef7 USD<\/strong> th\u1ec3 hi\u1ec7n s\u1ef1 t\u1ef1 tin c\u1ee7a ban l\u00e3nh \u0111\u1ea1o<\/li>\n<li><strong>\u0110\u1ed5i m\u1edbi trong pipeline<\/strong> &#8211; lenacapavir cho hi\u1ec7u qu\u1ea3 100% trong th\u1eed nghi\u1ec7m<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong> &#8211; S\u1eed d\u1ee5ng ph\u01b0\u01a1ng ph\u00e1p trung b\u00ecnh gi\u00e1 theo \u0111\u00f4 la v\u1edbi \u0111\u1ea7u t\u01b0 \u0111\u1ecbnh k\u1ef3 thay v\u00ec c\u1ed1 g\u1eafng b\u1eaft th\u1eddi \u0111i\u1ec3m th\u1ecb tr\u01b0\u1eddng<\/li>\n<li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o l\u1ee3i nhu\u1eadn<\/strong> &#8211; Theo d\u00f5i GILD quanh ng\u00e0y 5 th\u00e1ng 11 \u0111\u1ec3 t\u00ecm \u0111i\u1ec3m v\u00e0o ti\u1ec1m n\u0103ng<\/li>\n<li><strong>\u0110a d\u1ea1ng h\u00f3a kh\u00f4n ngoan<\/strong> &#8211; Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 10-15% danh m\u1ee5c v\u00e0o c\u1ed5 phi\u1ebfu d\u01b0\u1ee3c ph\u1ea9m<\/li>\n<li><strong>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc<\/strong>: &#8220;Giao d\u1ecbch GILD gi\u1ed1ng nh\u01b0 u\u1ed1ng thu\u1ed1c HIV c\u1ee7a h\u1ecd\u2014ki\u00ean \u0111\u1ecbnh h\u01a1n l\u00e0 b\u1eaft \u0111\u00fang th\u1eddi \u0111i\u1ec3m. B\u1ecf li\u1ec1u (ho\u1eb7c b\u1ecf nh\u1ecbp gi\u1ea3m gi\u00e1), b\u1ea1n s\u1ebd h\u1ed1i ti\u1ebfc sau!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Gilead Sciences, Inc. (GILD) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0111\u1ed9ng<\/th>\n<th>T\u1ea1i sao quan tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng \u0111\u1ea7u t\u01b0<\/td>\n<td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng cung c\u1ea5p c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n t\u1ea5t n\u1ea1p ti\u1ec1n t\u00e0i kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n d\u1ec5 qu\u1ea3n l\u00fd\u2014ngay c\u1ea3 50 USD c\u0169ng \u0111\u1ee7 cho \u0111\u1ea7u t\u01b0 c\u1ed5 phi\u1ebfu l\u1ebb<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>T\u00ecm m\u00e3 &#8220;GILD&#8221;<\/td>\n<td>D\u00f9ng \u0111\u00fang k\u00fd hi\u1ec7u, kh\u00f4ng ch\u1ec9 t\u00ecm &#8220;Gilead Sciences&#8221;<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td>\n<td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o; tr\u00e1nh l\u1ec7nh th\u1ecb tr\u01b0\u1eddng khi bi\u1ebfn \u0111\u1ed9ng<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td>\n<td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng\u2014nh\u1eafm d\u01b0\u1edbi 0,5% chi ph\u00ed giao d\u1ecbch<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i sao Pocket Option ph\u00f9 h\u1ee3p v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi<\/h2>\n<p>Pocket Option c\u00e1ch m\u1ea1ng h\u00f3a vi\u1ec7c ti\u1ebfp c\u1eadn c\u1ed5 phi\u1ebfu cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong>\u2014ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c kh\u00f4ng r\u1ee7i ro<\/li>\n<li><strong>Quy tr\u00ecnh KYC 1 ph\u00fat<\/strong>\u2014t\u1ea3i l\u00ean b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n n\u00e0o v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch ngay<\/li>\n<li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong>\u2014ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed, th\u1ebb ng\u00e2n h\u00e0ng v\u00e0 c\u00e1c l\u1ef1a ch\u1ecdn \u0111\u1ecba ph\u01b0\u01a1ng<\/li>\n<li><strong>C\u1ed5 phi\u1ebfu l\u1ebb c\u00f3 s\u1eb5n<\/strong>\u2014mua ph\u1ea7n nh\u1ecf c\u1ee7a GILD ngay c\u1ea3 v\u1edbi v\u1ed1n nh\u1ecf<\/li>\n<\/ul>\n<h2>\ud83c\udf0d Gilead Sciences n\u0103m 2025: Nh\u00e0 L\u00e3nh \u0110\u1ea1o \u0110\u1ed5i M\u1edbi Y T\u1ebf<\/h2>\n<p>Gilead Sciences th\u1ed1ng tr\u1ecb th\u1ecb tr\u01b0\u1eddng \u0111i\u1ec1u tr\u1ecb HIV v\u1edbi g\u1ea7n 50% th\u1ecb ph\u1ea7n M\u1ef9 cho Biktarvy. Ngo\u00e0i thu\u1ed1c kh\u00e1ng virus, c\u00f4ng ty d\u1eabn \u0111\u1ea7u nghi\u00ean c\u1ee9u ung th\u01b0 v\u00e0 \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh vi\u00eam. <strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025<\/strong>: Ph\u00ea duy\u1ec7t Yeztugo c\u1ee7a Gilead t\u1ea1o ra l\u1ef1a ch\u1ecdn ph\u00f2ng ng\u1eeba HIV \u0111\u1ea7u ti\u00ean ch\u1ec9 c\u1ea7n hai li\u1ec1u m\u1ed7i n\u0103m\u2014thay \u0111\u1ed5i cu\u1ed9c s\u1ed1ng h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi tr\u00ean to\u00e0n c\u1ea7u!<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Gilead Sciences (GILD)?","answer":"B\u1ea1n n\u00ean ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng \u0111\u1ea7u t\u01b0 h\u1ed7 tr\u1ee3 c\u1ed5 phi\u1ebfu NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb, n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu \"GILD\", ch\u1ecdn lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p v\u00e0 x\u00e1c nh\u1eadn giao d\u1ecbch."},{"question":"Gi\u00e1 c\u1ed5 phi\u1ebfu GILD hi\u1ec7n t\u1ea1i l\u00e0 bao nhi\u00eau?","answer":"T\u00ednh \u0111\u1ebfn ng\u00e0y 19 th\u00e1ng 8 n\u0103m 2025, gi\u00e1 c\u1ed5 phi\u1ebfu GILD l\u00e0 118,85 USD tr\u00ean NASDAQ."},{"question":"Nh\u1eefng r\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o Gilead Sciences l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro bao g\u1ed3m t\u1ea1m d\u1eebng th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng c\u1ee7a FDA, b\u1ea5t \u0111\u1ecbnh quy \u0111\u1ecbnh, ki\u1ec3m tra ph\u00e1p l\u00fd, doanh s\u1ed1 li\u1ec7u ph\u00e1p t\u1ebf b\u00e0o gi\u1ea3m v\u00e0 r\u1ee7i ro t\u1ef7 gi\u00e1 do doanh thu qu\u1ed1c t\u1ebf."},{"question":"T\u1ea1i sao n\u0103m 2025 l\u00e0 th\u1eddi \u0111i\u1ec3m t\u1ed1t \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu GILD?","answer":"N\u0103m 2025 c\u00f3 nhi\u1ec1u t\u00edn hi\u1ec7u t\u00edch c\u1ef1c nh\u01b0 ph\u00ea duy\u1ec7t Yeztugo, t\u0103ng tr\u01b0\u1edfng doanh s\u1ed1 Biktarvy, t\u00e0i ch\u00ednh m\u1ea1nh v\u00e0 ch\u01b0\u01a1ng tr\u00ecnh mua l\u1ea1i c\u1ed5 phi\u1ebfu l\u1edbn, t\u1ea1o c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 h\u1ea5p d\u1eabn."},{"question":"Pocket Option c\u00f3 l\u1ee3i \u00edch g\u00ec cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi?","answer":"Pocket Option cho ph\u00e9p n\u1ea1p t\u1ed1i thi\u1ec3u 5 USD, quy tr\u00ecnh KYC nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 h\u1ed7 tr\u1ee3 mua c\u1ed5 phi\u1ebfu l\u1ebb, r\u1ea5t ph\u00f9 h\u1ee3p cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Gilead Sciences (GILD)?","answer":"B\u1ea1n n\u00ean ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng \u0111\u1ea7u t\u01b0 h\u1ed7 tr\u1ee3 c\u1ed5 phi\u1ebfu NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb, n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu \"GILD\", ch\u1ecdn lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p v\u00e0 x\u00e1c nh\u1eadn giao d\u1ecbch."},{"question":"Gi\u00e1 c\u1ed5 phi\u1ebfu GILD hi\u1ec7n t\u1ea1i l\u00e0 bao nhi\u00eau?","answer":"T\u00ednh \u0111\u1ebfn ng\u00e0y 19 th\u00e1ng 8 n\u0103m 2025, gi\u00e1 c\u1ed5 phi\u1ebfu GILD l\u00e0 118,85 USD tr\u00ean NASDAQ."},{"question":"Nh\u1eefng r\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o Gilead Sciences l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro bao g\u1ed3m t\u1ea1m d\u1eebng th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng c\u1ee7a FDA, b\u1ea5t \u0111\u1ecbnh quy \u0111\u1ecbnh, ki\u1ec3m tra ph\u00e1p l\u00fd, doanh s\u1ed1 li\u1ec7u ph\u00e1p t\u1ebf b\u00e0o gi\u1ea3m v\u00e0 r\u1ee7i ro t\u1ef7 gi\u00e1 do doanh thu qu\u1ed1c t\u1ebf."},{"question":"T\u1ea1i sao n\u0103m 2025 l\u00e0 th\u1eddi \u0111i\u1ec3m t\u1ed1t \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu GILD?","answer":"N\u0103m 2025 c\u00f3 nhi\u1ec1u t\u00edn hi\u1ec7u t\u00edch c\u1ef1c nh\u01b0 ph\u00ea duy\u1ec7t Yeztugo, t\u0103ng tr\u01b0\u1edfng doanh s\u1ed1 Biktarvy, t\u00e0i ch\u00ednh m\u1ea1nh v\u00e0 ch\u01b0\u01a1ng tr\u00ecnh mua l\u1ea1i c\u1ed5 phi\u1ebfu l\u1edbn, t\u1ea1o c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 h\u1ea5p d\u1eabn."},{"question":"Pocket Option c\u00f3 l\u1ee3i \u00edch g\u00ec cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi?","answer":"Pocket Option cho ph\u00e9p n\u1ea1p t\u1ed1i thi\u1ec3u 5 USD, quy tr\u00ecnh KYC nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 h\u1ed7 tr\u1ee3 mua c\u1ed5 phi\u1ebfu l\u1ebb, r\u1ea5t ph\u00f9 h\u1ee3p cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-19T18:16:30+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD)\",\"datePublished\":\"2025-08-19T18:16:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"datePublished\":\"2025-08-19T18:16:30+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-19T18:16:30+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD)","datePublished":"2025-08-19T18:16:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","datePublished":"2025-08-19T18:16:30+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-gilead-sciences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Gilead Sciences, Inc. (GILD)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":339476,"slug":"how-to-buy-gilead-sciences","post_title":"Como comprar a\u00e7\u00f5es da Gilead Sciences, Inc. (GILD) - Investimento em a\u00e7\u00f5es da Gilead Sciences, Inc. (GILD)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-gilead-sciences\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/339478","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=339478"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/339478\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334054"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=339478"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=339478"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=339478"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}